The re-emergence of pertussis in Israel

Israel Medical Association Journal

Volumn 8, Issue 5, 2006, Pages 308-311

  Moerman, Larisa ^a   Leventhal, Alex ^a   Slater, Paul E ^a   Anis, Emilia ^a   Yishai, Ruth ^a   Marva, Esther ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

Epidemiology; Incidence; Israel; Pertussis; Re emergence

Indexed keywords

PERTUSSIS VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; HEALTH STATUS; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; ISRAEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; PERTUSSIS; POPULATION RESEARCH; PUBLIC HEALTH; RECURRENT INFECTION; RISK ASSESSMENT; RISK FACTOR; TIME SERIES ANALYSIS;

HOSPITALIZATION; HUMANS; INCIDENCE; ISRAEL; VACCINATION; WHOOPING COUGH;

EID: 33744489316     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. Department of Vaccines and Biologicals. Pertussis surveillance, A global meeting. WHO/V&B/01.19 Geneva, 2001.
2. Hewlett EL, Edwards KM. Pertussis - not just for kids. N Engl J Med 2005;352:1215-22.
3. Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001;20:641-6.
4. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000;182:1409-16.
5. CDC. Pertussis - United States, 1997-2000. MMWR 2002;51:73-6.
6. CCDR. Statement on adult/adolescent formulation of combined acellular pertussis, tetanus and diphtheria vaccine. Can Commun Dis Rep 2000:26 (ACS-1).
7. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emery Infect Dis 2000;6:348-57.
8. Baron S, Njamkepo E, Grimprel E, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998;17:412-8.
9. Klement E, Uliel L, Engel I, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003;131:1049-54.
10. CDC. Guidelines for the control of pertussis outbreaks. Atlanta, GA: US Department of Health and Human Services, CDC, 2000.
11. World Health Organization. Vaccines, Immunization and Biologicals. Geneva: WHO, 2003.
12. Van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples of patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996;174:89-96.
13. van Loo IH, van der Heide HG, Nagelkerke NJ, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis 1999;179:915-23.
14. Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol 2004;42:5453-7.
15. Tsang RS, Lau AK, Sill ML, et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004;42:5364-7.
16. Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2001;20:299-303.
17. Njamkepo E, Rimlinger F, Thiberge S, Guiso N. Thirty-five years experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine 2002;20:1290-4.
18. Forsyth KD, Campins-Marti M, Caro J, et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004;39:1802-9.
19. Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States. Pediatr Infect Dis J 2005;24: S141-6.
20. CDC. Recommended Childhood and Adolescent Immunization schedule - United States, 2006. MMWR 2006,54(52):Q1-4.
21. Halperin SA. Pertussis - A disease and vaccine for all ages. N Engl J Med 2005;353:1615-17.